Solana Company logo

Solana Company

HSDT

NASDAQFinancial ServicesAsset Management

Previous close

$2.10

+$0.24 · +12.90%

Aug 21, 4:00 PM ET

HSDT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

58

Fair Value

Momentum

22

Weakening

Sentiment

63

Bullish

Risk resilience

28

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

Industry
Asset Management
Sector
Financial Services
Headquarters
US
CEO
Dane Carl Andreeff
Listed since
Jun 27, 2014
Employees
21

Market position

Day range

Current $2.10

52-week range

Current $2.10

Open
$1.945
Previous close
$1.86
Volume
783.84K
2.96× average
Average volume
264.71K
Average daily volume
Market cap
122.61M USD
Beta
1.01
Market reference 1
50-day average
$1.7063
+23.07% above average
200-day average
$2.4212
-13.27% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
56.44M USD
P/E (TTM)
-0.07×
P/B (TTM)
0.99×
P/S (TTM)
10.16×
EV / EBITDA
-1.43×
Earnings yield
-64.17%
Free cash flow yield
-96.19%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
95.53%
Operating margin
-200.47%
Net margin
-1302.78%
Return on equity
-13.59%
Return on assets
-13.45%
Return on invested capital
-7.02%

Financial health

Debt / equity
Current ratio
10.33×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends448%-978%-2405%-3832%Gross margin, FY2021: 42.91%Gross margin, FY2022: 41.17%Gross margin, FY2023: 9.47%Gross margin, FY2024: -11.92%Gross margin, FY2025: 91.69%Operating margin, FY2021: -3475.48%Operating margin, FY2022: -1971.54%Operating margin, FY2023: -1929.81%Operating margin, FY2024: -2673.65%Operating margin, FY2025: -351.02%Net margin, FY2021: -3473.56%Net margin, FY2022: -1788.06%Net margin, FY2023: -1374.22%Net margin, FY2024: -2258.08%Net margin, FY2025: -679.57%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 42.91%. Gross margin FY2022 41.17%. Gross margin FY2023 9.47%. Gross margin FY2024 -11.92%. Gross margin FY2025 91.69%. Operating margin FY2021 -3475.48%. Operating margin FY2022 -1971.54%. Operating margin FY2023 -1929.81%. Operating margin FY2024 -2673.65%. Operating margin FY2025 -351.02%. Net margin FY2021 -3473.56%. Net margin FY2022 -1788.06%. Net margin FY2023 -1374.22%. Net margin FY2024 -2258.08%. Net margin FY2025 -679.57%.

Income trends

Revenue

6.02M USD+1057.12%

Operating income

−21.12M USD-51.92%

Net income

−40.89M USD-248.24%
Income trends across reported periods10.71M USD−8.06M USD−26.82M USD−45.58M USDRevenue, FY2021: 522K USDRevenue, FY2022: 787K USDRevenue, FY2023: 644K USDRevenue, FY2024: 520K USDRevenue, FY2025: 6.02M USDOperating income, FY2021: −18.14M USDOperating income, FY2022: −15.52M USDOperating income, FY2023: −12.43M USDOperating income, FY2024: −13.9M USDOperating income, FY2025: −21.12M USDNet income, FY2021: −18.13M USDNet income, FY2022: −14.07M USDNet income, FY2023: −8.85M USDNet income, FY2024: −11.74M USDNet income, FY2025: −40.89M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 522K USD. Revenue FY2022 787K USD. Revenue FY2023 644K USD. Revenue FY2024 520K USD. Revenue FY2025 6.02M USD. Operating income FY2021 −18.14M USD. Operating income FY2022 −15.52M USD. Operating income FY2023 −12.43M USD. Operating income FY2024 −13.9M USD. Operating income FY2025 −21.12M USD. Net income FY2021 −18.13M USD. Net income FY2022 −14.07M USD. Net income FY2023 −8.85M USD. Net income FY2024 −11.74M USD. Net income FY2025 −40.89M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue6.02M USD520K USD644K USD787K USD522K USD
Cost of goods sold500K USD582K USD583K USD463K USD298K USD
Gross profit5.52M USD−62K USD61K USD324K USD224K USD
Research and development3.51M USD3.66M USD2.94M USD4.26M USD5.99M USD
Selling, general, and administrative23.13M USD10.12M USD9.27M USD10.64M USD12.18M USD
Operating expenses26.64M USD13.84M USD12.49M USD15.84M USD18.37M USD
Interest income257K USD
Interest expense635K USD17K USD834K USD
Depreciation and amortization680K USD60K USD162K USD255K USD312K USD
Operating income−21.12M USD−13.9M USD−12.43M USD−15.52M USD−18.14M USD
Net income−40.89M USD−11.74M USD−8.85M USD−14.07M USD−18.13M USD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-1.85
FY2025
Latest fiscal-year revenue
6.02M USD
FY2025 · +1057.12% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend16.42-56.65-129.71-202.78FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend6.57M4.37M2.17M-29.7KFY21FY22FY23FY24FY25

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

5 ratings
Strong buy00%
Buy360%
Hold240%
Sell00%
Strong sell00%

Recent analyst actions

2 institutions
B. Riley SecuritiesmaintainBuy
Roth MKMmaintainBuy

HSDT news

Corporate actions

Corporate action history

Stock split

Effective Jul 1, 2025

1:50

Stock split

Effective May 2, 2025

1:15

Stock split

Effective Aug 17, 2023

1:50

Stock split

Effective Jan 4, 2021

1:35

Stock split

Effective Jan 23, 2018

1:5

HSDT peers

ETFs holding HSDT

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research HSDT

research.disclaimer